Higher anticholinergic burden from medications is associated with significant increase in markers of inflammation in the EPIC-Norfolk prospective population-based cohort study.
Br J Clin Pharmacol
; 88(7): 3297-3306, 2022 07.
Article
in En
| MEDLINE
| ID: mdl-35118716
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Interleukin-6
/
Cholinergic Antagonists
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prevalence_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Br J Clin Pharmacol
Year:
2022
Type:
Article
Affiliation country:
United kingdom